Nuchal translucency measurement in fetuses with spinal muscular atrophy

Prenatal Diagnosis

Volumn 31, Issue 4, 2011, Pages 327-330

  Zadeh, Neda ^a   Hudgins, Louanne ^a   Norton, Mary E ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Nuchal translucency; Prenatal screening; Spinal muscular atrophy

Indexed keywords

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BIRTH; CLINICAL ARTICLE; FAMILY; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; INFANCY; INFANT; INFORMATION; MEDICAL LITERATURE; MOTIVATION; NORMAL VALUE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PRIORITY JOURNAL; SPINAL MUSCULAR ATROPHY; SUPPORT GROUP; ULTRASOUND;

FEMALE; FETUS; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; MUSCULAR ATROPHY, SPINAL; NUCHAL TRANSLUCENCY MEASUREMENT; PHENOTYPE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, PRENATAL;

EID: 79952714258     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2646     Document Type: Article

References (12)

1. ACOG Committee on Practice Bulletins. 2007. Screening for fetal chromosome abnormalities: ACOG Practice Bulletin No. 77. Obstet Gynecol 109(1): 217-227.
2. ACOG Committee Opinion. 2009. ACOG Committee Opinion No. 432. Spinal muscular atrophy. Obstet Gynecol 113: 1194-1196.
3. Bilardo CM, Pajkrt E, de Graaf B, Mol W, Bleker OP. 1998. Outcome of fetuses with enlarged nuchal translucency and normal karyotype. Ultrasound Obstet Gynecol 11: 401-406.
4. Bilardo CM, Timmerman E, Pajkrt E, van Maarle M. 2010. Increased nuchal translucency in euploid fetuses-what should we be telling the parents? Prenat Diagn 30: 93-102.
5. de Jong-Pleij EA, Stoutenbecek P, van de Mark-Batseva NN, et al. 2002. The association of spinal muscular atrophy type II and increased nuchal translucency. Ultrasound Obstet Gynecol 19(3): 312-313.
6. Nicolaides KH, Azar J, Byrne D, et al. 1992. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 304: 867-869.
7. Rijhsinghani A, Yankowitz J, Howser D, Williamson R. 1997. Sonographic and maternal serum screening abnormalities in fetuses affected by spinal muscular atrophy. Prenat Diagn 17(2): 166-169.
8. Souka AP, Krampl EK, Bakalis S, et al. 2001. Outcomes of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol 18: 9-17.
9. Souka AP, Snijders RGM, Novakov A, et al. 1998. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 11: 391-400.
10. Souka AP, von Kaisenberg CS, Hyett JA, et al. 2005. Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol 192: 1005-1021.
11. Stiller RJ, Liberson D, Herzlinger R, et al. 1999. The association of increased fetal nuchal translucency and spinal muscular atrophy type I. Prenat Diagn 19: 587-589.
12. Van Vugt JMG, Tinnemans BWS, Van Zalen-Sprock RM. 1998. Outcome and early childhood follow-up of chromosomally normal fetuses with increased nuchal translucency at 10-14 weeks gestation. Ultrasound Obstet Gynecol 11: 407-409.